Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
March 2013 Volume 42 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March 2013 Volume 42 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells

  • Authors:
    • Yeong-Ae Seong
    • Pyung-Gyun Shin
    • Gun-Do Kim
  • View Affiliations / Copyright

    Affiliations: Department of Microbiology, College of Natural Sciences, Pukyong National University, Busan 608-737, Republic of Korea, Mushroom Science Division, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong 369-873, Republic of Korea
  • Pages: 1045-1051
    |
    Published online on: January 8, 2013
       https://doi.org/10.3892/ijo.2013.1763
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Anacardic acid (AA) is a constituent of the cashew nut shell and is known as an inhibitor of nuclear factor-κB (NF-κB). We investigated the cytotoxicity of AA on cancer cells and more experiments to reveal the cell death mechanism focused on A549 lung adenocarcinoma cells for our interest in lung cancer. To examine the molecular mechanism of cell death in AA treated A549 cells, we performed experiments such as transmission electron microscopy (TEM), western blot analysis, fluorescence-activated cell sorting (FACS), genomic DNA extraction and staining with 4',6-diamidino-2-phenylindole (DAPI). For the first time we revealed that AA induces caspase‑independent apoptosis with no inhibition of cytotoxicity by pan-caspase inhibitor, Z-VAD-fmk, in A549 cells. Our results showed the possibility of mitochondrial-mediated apoptosis through the activation of apoptosis-inducing factor (AIF) and an intrinsic pathway executioner such as cytochrome c. This study will be helpful in revealing the cell death mechanisms and in developing potential drugs for lung cancer using AA.

Introduction

According to the 2009 annual report from the National Cancer Institute (NCI), the rates of new diagnose and death from all cancers combined have declined significantly for men and women, but the incidence rate for lung cancer in women has increased.

Anacardic acid (2-hydroxy-6-pentadecylbenzoic acid, AA; Fig. 1) is a constituent of the shell of the cashew-nut (Anacardium occidentale) (1) and has been discovered in many plants including Ginkgo biloba(2). AA has a number of roles including the inhibition of lipid synthesis, enzyme activity such as lipoxygenase, prostaglandin endoperoxide synthase and histone acetyltransferase and the expression of nuclear factor-κB (NF-κB) as well as the activation of aurora kinase A (2–6). Additionally, AA has an antibacterial and anticancer effect (7,8).

Figure 1

The structure of anacardic acid (AA, MW: 348.5).

The name ‘apoptosis’ coined by Kerr et al is classified as a type I programmed cell death (PCD) (9). Apoptosis is a physiological process characterized by chromatin condensation, nuclear fragmentation, DNA fragmentation and final removal by phagocytosis (10). Cell death is frequently thought to be ‘caspase-independent’ when it is not suppressed by broad-spectrum caspase inhibitors such as N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-fmk). However, the efficiency of Z-VAD-fmk is different from caspases and it also inhibits calpains and cathepsins, especially at high concentrations (10 μM) (10).

The main pathways of apoptosis are the death receptor pathway (extrinsic) and the mitochondrial pathway (intrinsic). When the apoptotic ligands bind to death receptors, the extrinsic pathway occurs through the activation of initiators such as caspases 8 and 10, and the activation of executioners, caspases 3, 6, and 7 resulting in DNA fragmentation (11–13). The mitochondrion is an essential mediator of the intrinsic pathway. The arrival of signals leading to changes in permeability of the outer mitochondrial membrane is the cause of the releasing intermitochondrial apoptotic molecules into the cytosol (14,15). Cytochrome c, one of the best characterized pro-apoptotic molecules, leads to activation of caspases via the formation of the apoptosome (16). AIF, a phylogenetically conserved mitochondrial flavoprotein, also has a key role in apoptosis. When apoptosis is induced, AIF relocates from the mitochondria to the nucleus where it mediates chromatin condensation and large-scale DNA fragmentation (17,18).

The experiments reported in this research were designed to investigate the cytotoxic effect on cancer cells and to find the potential cell signaling pathways leading to cell death on AA treated human lung adenocarcinoma A549 cells.

Materials and methods

Cell culture and reagents

A549 (human lung adenocarcinoma), HEK293 (human embryonic kidney cell), HepG2 and SK-Hep1 (human hepatocarcinoma) were purchased from the American Tissue Culture Collection (Manassas, VA, USA). Cells were cultured in RPMI-1640 (A549), DMEM (HEK293), EMEM (HepG2 and SK-Hep1) (HyClone Laboratories, Logan, UT, USA) medium supplemented with 10% heat inactivated fetal bovine serum (FBS; HyClone Laboratories), 100 U/ml penicillin and 10 μg/ml streptomycin (PAA Laboratories GmbH, Pasching, Austria) in a humidified atmosphere containing 5% CO2 at 37°C. Except the cells were used in the cell viability, A549 cells were investigated, after incubation in the FBS-free RPMI-1640 medium for 24 h, anacardic acid (AA), Calbiochem (San Diego, CA, USA) was added to the medium. Pan-caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-fmk) was purchased from Sigma-Aldrich (St. Louis, MO, USA).

Cell cytoxicity

The exponential phase of cells were seeded into the wells of 96-well plates at an initial density of 0.5×105–1×105 cells in medium containing 10% FBS per well of 100 μl. Following 24 h of incubation, AA, dissolved in 100% dimethyl sulfoxide (DMSO; Sigma-Aldrich), was added to the culture medium at various concentrations. Cells were incubated for 24 h and 10 μl of EZ-Cytox Cell Viability Assay Solution (WST-1™; Daeil Lab Service, Seoul, Korea) was added and incubated for 4 h at 37°C. The intensity was measured at 450 nm using an ELISA reader (Molecular Devices, Sunnyvale, CA, USA).

Western blot analysis

A549 cell lysates were prepared in a Radioimmunoprecipitation assay buffer (RIPA, Cell Signaling Technology, Danvers, MA, USA) and proteins were visualized using enhanced chemiluminescent (ECL) detection solution (Pierce Biotechnology, Rockford, IL, USA). Antibodies include anti-cleaved caspase 3, anti-cleaved caspase 7, anti-cytochrome c, anti-Bax, anti-Bad, anti-Bak, anti-Bcl-XL, anti-cleaved PARP, anti-FoxO1, anti-FoxO3a, anti-FoxO4, anti-β-actin, secondary rabbit and mouse antibodies conjugated with HRP were purchased from Cell Signaling Technology. Anti-AIF, anti-Hsp70, anti-polyclonal Hsp27, anti-Noxa, anti-STRAP, anti-Bim and secondary antibodies conjugated with HRP rabbit goat were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

DAPI staining

4′,6-diamidino-2-phenylindole (DAPI) staining was used for the morphological observation of apoptosome. A549 cells were seeded in plates, and the cells were treated with or without AA (3 μg/ml) for 24 h, then the cells were washed with PBS. Two-to-three milliliters of diluted DAPI was added to the cells and incubated for 15 min at 37°C. The cells were rinsed once with methanol and the result was analyzed by fluorescence microscopy using an Eclipse 50i microscope.

TEM

For observation of more detailed morphological features, transmission electron microscopy (TEM) was used. Cultured A549 cells were pre-fixed in pellets at 4°C with 2.5% glutaraldehyde in 0.1 M phosphate buffer and then post-fixed with 1% osmium tetraoxide (OsO4) in 0.1 M phosphate buffer, pH 7.4. After fixing, cells were embedded in Epon 812 using routine procedures. Approximately 70 μm ultrasected specimens by Ultracut Reichert-jung were stained using uranyl acetate and lead citrate, and examined with Hitachi H600 TEM (Tokyo, Japan). All reagents used in the TEM experiment were purchased from Electron Microscopy Science (EMS).

FACS analysis

A549 cells were harvested by trypsinization and fixed with ice-cold ethanol (70%) for 5 h at 4°C. Followed resuspending with PBS containing RNase A (0.2 μg/ml) and incubation for 1 h at 37°C. Cells were stained with propidium iodide (40 μg/ml) for 30 min. The distribution of sub-G1 DNA content was analyzed using the FACS Calibur apparatus (Becton-Dickinson, Mountain View, CA, USA).

Genomic DNA extraction

For analyzing DNA fragmentation, genomic DNA was extracted using DNeasy Blood and Tissue kit purchased from Qiagen Inc. (Valencia, CA, USA) to the manufacturer’s protocol.

Results

Cytotoxicity of AA

In order to investigate the cytotoxicity, we used a normal cells (HEK293), and lung (A549) and liver (HepG2, SK-Hep1) cancer cells were treated with AA in a dose-dependent manner. After 24 h of exposure, the results of cell viability assay showed that AA inhibits the proliferation of all cells used. Although AA inhibited cellular proliferation of HEK cells, the cytotoxicity was less than cancer cells (Fig. 2A). To study the effect of the caspase inhibitor, cells were pretreated for 2 h with the cell-permeable and irreversible pan-caspase inhibitor Z-VAD-fmk (100 μM) and then exposed to AA for 24 h in the continued presence of Z-VAD-fmk. Viability was then assessed by MTT assay using WST-1™ and the result showed Z-VAD-fmk did not inhibit the cell viability in AA treated A549 cells (Fig. 2B). Considering our interest in lung cancer, we used A549 cells for further research and the IC50 value of AA treated A549 cells was 2.75±0.25 μg/ml. Therefore, we used 3.0 μg/ml of AA for investigating the molecular mechanism of cell death in A549. Cellular morphology of AA treated A549 cells were shown under a microscope and cytotoxicity was increased dose-dependently (Fig. 2C).

Figure 2

Cell viability in AA treated cell lines. (A) Cell viability was examined with a WST-1 assay. Cell growth was inhibited on a dose-dependent manner in AA treated cells. (B) The A549 cells were pretreated for 2 h with the cell-permeable, irreversible pancaspase inhibitor Z-VAD-fmk (100 μM) and then 3.0 μg/ml of AA for 24 h in the continued presence of Z-VAD-fmk. Viability was then assessed by WST-1 assay. (C) A549 cells were incubated with AA for the indicated concentrations and analyzed under a microscope: (a) control cells; (b–f) 1.0, 2.0, 3.0, 4.0 and 5.0 μg/ml of AA, respectively.

Induction of apoptosis in AA treated A549 cells

In order to further elucidate the nature of AA induced cell death in A549, we investigated the nuclear morphology of AA treated cells by using 4′,6-diamidino-2-phenylindole (DAPI) staining. The results showed totally different patterns between the AA-treated and -untreated cells. AA treated cells exhibited formations of apoptosome (Fig. 3A–b), indicating that AA induces apoptosis in A549 cells. For further evidence of apoptosis, we analyzed the fragmentation of chromosomal DNA by using agarose gel electrophoresis (Fig. 3B). The fragmentation of chromosomal DNA by AA increased to the exposure time (Fig. 3B-b, c and d), while it was not observed in the untreated cells (Fig. 3B-a). In addition, to study the cell death induced by AA, we quantified the sub-G1 DNA content by fluorescence activated cell sorting (FACS) analysis. The sub-G1 genomic DNA content was gradually increased after 6, 12 and 24 h to 7.58, 14.01 and 38.79%, respectively (Fig. 3C). TEM also showed apoptotic features such as chromatin condensation and nuclear fragmentation (Fig. 3D-b). These results support the view that AA plays a major role in apoptosis induction in A549 cells.

Figure 3

Induction of apoptosis in AA treated A549 cells. (A) The formation of apoptosome by AA was investigated by DAPI staining; (a) untreated cells; (b) apoptosome was seen in the cells treated with 3.0 μg/ml of AA for 24 h. (B) DNA fragmentation assay; (a), untreated cells; (b–d) AA treated cells for 6, 12 and 24 h, respectively. The results were obtained by 1.5% agarose gel electrophoresis. (C) Quantification of sub-G1 DNA content in A549 cells treated with 3.0 μg/ml of AA for 0, 6, 12 and 24 h were analyzed by FACS. (D) The induction of chromatin condensation and nuclear cleavage by AA were analyzed under TEM; (a) untreated cells; (b) cells treated with 3.0 μg/ml of AA for 24 h; n, nuclear. Bars: a, b, 1 μm.

Effect of AA on the intrinsic pathway of apoptosis in A549 cells

To determine the apoptosis signaling pathway induced by AA, we analyzed the expression of several genes using western blot analysis. Cleaved caspase 3, cleaved caspase 7 and cytochrome c, known as the executioners of the intrinsic pathway, showed gradual increase in a time dependent manner on AA treated A549 cells. Caspase 9 was also analyzed (Fig. 4A). In addition, the expression of pro- and anti-apoptotic Bcl-2 family was determined. Pro-apoptotic members of the Bcl-2 family, Bim, Bad, Bak and Noxa increased, and the anti-apoptotic member Bcl-xL, decreased (Fig. 4B). The expression of Bak and Bad showed gradual increase time-dependently with AA-treatment and the expression of Bax and Noxa showed further increased level at 12 h after AA exposure. Bim has three isoforms (BimS, BimL and BimEL) with different intrinsic toxicities and promotes apoptosis (19). The cleaved form of Bim appeared at 6 h and the expression of Bcl-xl decreased gradually to 18 h after AA exposure.

Figure 4

Time-dependent expression of apoptotic proteins in AA treated A549 cells. Whole-cell extracts were prepared and analyzed by western blotting. (A) Induction of intrinsic apoptosis pathway related proteins. (B) Expression of pro- and anti-apoptotic BCL-2 family proteins. (C) Expression of AIF and cleaved PARP. (D) Decrease of anti-apoptotic chaperone protein, Hsp70 and cofactor. (E) Expression of FoxOs.

Effects of AA on AIF related pathway

Because the inhibition of the pan-caspase inhibitor, Z-VAD-fmk, failed to prevent cell death, we analyzed the possibility of a caspase-independent pathway by apoptogenic molecules, apoptosis-inducing factor (AIF). Poly (ADP-ribose) polymerase-1 (PARP-1), the mediator of AIF release, was also investigated. The expression of AIF showed gradual increase, as did the cleaved PARP-1 after 18 h (Fig. 4C).

Decrease of the chaperone genes

We examined the expression of several genes that encode proteins known as molecular chaperones by assisting the correct folding of nascent and stress-accumulated misfolded proteins (20). We investigated the expression of Hsp70 and Strap, stress-responsive activator of p300 and the results showed downregulation of Hsp70 and Strap by AA (Fig. 4D).

Activation of forkhead transcription factors by AA

Members of the non-phosphorylated mammalian forkhead transcription factors (FoxOs) are involved in regulating the expression of genes involved in apoptosis. FoxO1, FoxO4 and FoxO3a are known as mammalian forkhead transcription factors that trigger the up-regulation of proteins such as Bim and NOXA (21). The expression of FoxO1, FoxO4 and FoxO3a in AA treated A549 cells increased with the optimal expression time being slightly different depending on the subfamily (Fig. 4E).

Discussion

The current study focused on the findings of a cell signaling pathway leading to death in A549 cells by AA. Our research provides strong evidence to support the view that AA induces apoptosis in a caspase-independent manner with no inhibition of cytotoxicity by pan-caspase inhibitor, Z-VAD-fmk, in A549 cells. In addition to the morphological features by TEM and microscopy and FACS analysis, the analysis of gene expression by western blotting demonstrates the induction of apoptosis by AA.

Previous research reported that the release of cytochrome c from mitochondria is an early event during apoptosis, and pro-apoptotic Bcl-2 family members induce the release of cytochrome c and anti-apoptotic Bcl-2 proteins inhibit the release of cytochrome c(22,23). The balance between the pro-apoptotic (Bid, Bad, Bim, Bax, Bak and Noxa) and anti-apoptotic (Bcl-2, Bcl-xL, A1 and Bcl-w) Bcl-2 protein families is an important factor contributing to cytochrome c release, and in determining cell fate (24,25). Following cytochrome c release, caspases are activated and the cell undergoes apoptosis through the formation of apoptosomes, Apaf-1/caspase 9 complex (25). Bax and Bak are also known to promote apoptosis by modulating ER and mitochondrial Ca2+ stores (26). We are studying on the possibility of apoptosis by ER stress. The pro-apoptotic BH3-only protein Bim, induces cell death by binding the anti-apoptotic Bcl-2 family protein and Noxa is known as a mediator of p53-induced apoptosis (27). The expression of Bim and Noxa is regulated by the transcription factor of Forkhead (FKHR) in the rhabdomyosarcoma family including FoxO (21). FoxO transcription factors modulate the expression of genes involved in apoptosis, cell cycle, cell differentiation and other cellular functions (28). In this study, AA induced the expression of the pro-apoptotic Bcl-2 family proteins, Bim, Bad, Bak, Bax and Noxa and cytochrome c, and reduced the expression of the anti-apoptotic Bcl-2 family protein, Bcl-XL, in A549 cells. The expression of FoxOs increased on AA treated A549 cells. These results showed the possibility that the increase of pro-apoptotic BH3-only protein, Bim and Noxa by FoxOs and decrease of anti-apoptotic protein, Bcl-XL, induce the outer membrane disruption of mitochondria in AA treated A549. The disruption of mitochondria membrane may induce the release of proapoptotic mediators such as AIF and cytochrome c from mitochondria.

Mitochondrial intermembrane flavoprotein AIF was originally characterized as a cell death mediator (17) and AIF has a potential role as a prognostic marker and a target for radiochemotherapeutic intervention in CH27 human lung carcinoma cells (29). AIF translocate from mitochondria to the cytosol and then move to the nucleus to cause peripheral chromatin condensation and large scale fragmentation of DNA (17,18,30). AIF is an important mitochondrial protein involved in caspase-dependent and -independent pathways (31). One well-known mechanism to release AIF from mitochondria is by the activation of poly (ADP-ribose) polymerase-1 (PARP-1) which is a key molecule in AIF-induced cell death and mediates the release and translocation of AIF (32).

While PARP-1 is involved in the release of AIF from mitochondria (32), heat shock protein 70 (Hsp70) negatively regulates the AIF function by inhibiting translocation to the nucleus (33). Furthermore, Hsp70 inhibits apoptosis through the inhibition of a downstream pathway of cytochrome c release, upstream of caspase 3 activation and Apaf-1 apoptosome formation (33–35). Hsps also block caspase-dependent and -independent apoptosis in Jurkat T cells (36) and a depletion of Hsp70 produces apoptosis-like death in various tumor cell types, including human oral carcinoma cells (37). Heat shock proteins are important prognostic factors in malignant diseases due to their abundant expression in many cancer cells. Strap is known as the Hsp70 transcription cofactor (38). Current results show the possibility that the decrease of Hsp70 and increase of proapoptotic protein AIF and PARP-1 promote chromatin condensation and DNA fragmentation and induce apoptosis in AA treated A549 cells.

In conclusion, for the first time our research suggests that AA induces caspase-independent apoptosis, that the pan-caspase inhibitor z-VAD-fmk does not inhibit cell death, and the activation of a mitochondrial-mediated cell death signaling pathway have a major role in apoptotic cell death in A549 cells. The release of the intermembrane proapoptotic factors from the mitochondria by imbalances between pro- and anti-apoptotic Bcl-2 family members, decrease of Hsp70 and increase of AIF could have a key role in apoptosis in AA treated A549 cells. Based on our results, we suggest (Fig. 5) the possible signaling pathway leading to apoptosis in AA treated A549.

Figure 5

Potential apoptosis pathway of AA treated A549 cells. The release of the intermembrane proapoptotic factors from the mitochondria by imbalances between pro- and anti-apoptotic Bcl-2 family members, decrease of Hsp 70 and increase of AIF could have a key role in mitochondrial-mediated apoptosis in AA-treated A549 cells.

Acknowledgements

This study was supported by a grant from the Next-Generation BioGreen 21 Program (SSAC, grant no. PJ008171), Rural Development Administration, Republic of Korea.

References

1 

Kubo I, Kinst-Hori I and Yokokawa Y: Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod. 57:545–551. 1994. View Article : Google Scholar : PubMed/NCBI

2 

Murata M, Irie J and Homma S: Inhibition of lipid synthesis of bacteria, yeast and animal cells by anacardic acids, glycerol-3-phosphate dehydrogenase inhibitors from Ginkgo. Lebensm Wiss Technol. 30:458–463. 1997. View Article : Google Scholar

3 

Grazzini R, Hesk D, Heininger E, et al: Inhibition of lipoxygenase and prostaglandin endoperoxide synthase by anacardic acids. Biochem Biophys Res Commun. 176:775–780. 1991. View Article : Google Scholar : PubMed/NCBI

4 

Kishore AH, Vedamurthy BM, Mantelingu K, et al: Specific small-molecule activator of aurora kinase A induces autophosphorylation in a cell-free system. J Med Chem. 28:792–797. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Sun Y, Jiang X, Chen S and Price BD: Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett. 580:4353–4356. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M and Aggarwal BB: Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaB alpha kinase, leading to potentiation of apoptosis. Blood. 111:4880–4891. 2008.

7 

Choi JG, Jeong SI, Ku CS, Sathishkumar M, Lee JJ, Mun SP and Kim SM: Antibacterial activity of hydroxyalkenyl salicylic acids from sarcotesta of Ginkgo biloba against vancomycin-resistant Enterococcus. Fitoterapia. 80:18–20. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Sukumari-Ramesh S, Singh N, Jensen MA, Dhandapani KM and Vender JR: Anacardic acid induces caspase-independent apoptosis and radiosensitizes pituitary adenoma cells. J Neurosurg. 114:1681–1690. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI

10 

Kroemer G, Galluzzi L, Vandenabeele P, et al: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16:3–11. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Millan A and Huerta S: Apoptosis-inducing factor and colon cancer. J Surg Res. 151:163–170. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Slee EA, Adrain C and Martin SJ: Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem. 276:7320–7326. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Walczak H and Krammer PH: The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res. 256:58–66. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Zamzami N, Susin SA, Marchetti P, Hirsch T, Gómez-Monterrey I, Castedo M and Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med. 183:1533–1544. 1996. View Article : Google Scholar : PubMed/NCBI

15 

Schultz DR and Harrington WJ Jr: Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum. 32:345–369. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Adrain C and Martin SJ: The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci. 26:390–397. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Susin SA, Lorenzo HK, Zamzami N, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Ye H, Cande C, Stephanou NC, et al: DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol. 9:680–684. 2002. View Article : Google Scholar : PubMed/NCBI

19 

O’Connor L, Strasser A, O’Reilly LA, Hausmann G, Adams JM, Cory S and Huang DC: Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17:384–395. 1998.

20 

Beckmann RP, Mizzen LE and Welch WJ: Interaction of Hsp70 with newly synthesized proteins: implications for protein folding and assembly. Science. 248:850–854. 1990. View Article : Google Scholar : PubMed/NCBI

21 

Obexer P, Geiger K, Ambros PF, Meister B and Ausserlechner MJ: FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14:534–547. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI

23 

Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI

24 

Green DR and Amarante-Mendes GP: The point of no return: mitochondria, caspases, and the commitment to cell death. Results Probl Cell Differ. 24:45–61. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:479–489. 1997. View Article : Google Scholar : PubMed/NCBI

26 

Nutt LK, Pataer A, Pahler J, Fang B, Roth J, McConkey DJ and Swisher SG: Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J Biol Chem. 277:9219–9225. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Oda E, Ohki R, Murasawa H, et al: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:1053–1058. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Huang H and Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Leung HW, Wu CH, Lin CH and Lee HZ: Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol. 508:77–83. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Zhang X, Chen J, Graham SH, et al: Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem. 82:181–191. 2002. View Article : Google Scholar

31 

Cregan SP, Dawson VL and Slack RS: Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene. 23:2785–2796. 2004. View Article : Google Scholar : PubMed/NCBI

32 

Yu SW, Wang H, Poitras MF, et al: Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 297:259–263. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Gurbuxani S, Schmitt E, Cande C, et al: Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 22:6669–6678. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Li CY, Lee JS, Ko YG, Kim JI and Seo JS: Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem. 275:25665–25671. 2000. View Article : Google Scholar : PubMed/NCBI

35 

Saleh A, Srinivasula SM, Balkir L, Robbins PD and Alnemri ES: Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2:476–483. 2000. View Article : Google Scholar : PubMed/NCBI

36 

Creagh EM, Carmody RJ and Cotter TG: Heat shock protein 70 inhibits caspase-dependent and -independent apoptosis in Jurkat T cells. Exp Cell Res. 257:58–66. 2000. View Article : Google Scholar : PubMed/NCBI

37 

Nylandsted J, Wick W, Hirt UA, et al: Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res. 62:7139–7142. 2002.PubMed/NCBI

38 

Xu D, Zalmas LP and La Thangue NB: A transcription cofactor required for the heat-shock response. EMBO Rep. 9:662–669. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Seong Y, Shin P and Kim G: Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells. Int J Oncol 42: 1045-1051, 2013.
APA
Seong, Y., Shin, P., & Kim, G. (2013). Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells. International Journal of Oncology, 42, 1045-1051. https://doi.org/10.3892/ijo.2013.1763
MLA
Seong, Y., Shin, P., Kim, G."Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells". International Journal of Oncology 42.3 (2013): 1045-1051.
Chicago
Seong, Y., Shin, P., Kim, G."Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells". International Journal of Oncology 42, no. 3 (2013): 1045-1051. https://doi.org/10.3892/ijo.2013.1763
Copy and paste a formatted citation
x
Spandidos Publications style
Seong Y, Shin P and Kim G: Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells. Int J Oncol 42: 1045-1051, 2013.
APA
Seong, Y., Shin, P., & Kim, G. (2013). Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells. International Journal of Oncology, 42, 1045-1051. https://doi.org/10.3892/ijo.2013.1763
MLA
Seong, Y., Shin, P., Kim, G."Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells". International Journal of Oncology 42.3 (2013): 1045-1051.
Chicago
Seong, Y., Shin, P., Kim, G."Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells". International Journal of Oncology 42, no. 3 (2013): 1045-1051. https://doi.org/10.3892/ijo.2013.1763
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team